lymphocytic carcinoma
Conditions
Interventions
only chemotherapy:chemotherapy
digoxin+chemotherapy:digoxin+chemotherapy
Sponsors
The Affiliated DrumTower Hospital of Nanjing University Medical School
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patiens should meet all of the following requirement: 1. Patients diagnosised acute leukemia or diffuse large B cell lymphoma or indolent lymphoma; 2. Aged from 18y to 65y; 3. ECOG<2; 4. Signed informed consent and willing to follow-up visit.
Exclusion criteria
Exclusion criteria: Patiens should be excluded if she/he meet one of the following requirement 1. To be with arrhythmia history; 2. To be with hypertrophic obstructive cardiomyopathy history; 3. Pre-excitation syndrome syndrome associated with atrial fibrillation or flutter poorly controlled hypertension patients; 4. Serious electrolyte disturbances including serum K ,Ca, and Mg; 5. Women during pregnancy or lactation ,mental disorder; 6. Adequate liver and renal function within 2 weeks of Screening: 7. Bilirubin>14mg/LAlanine aminotransferase (ALT) or Aspartate aminotransferase (AST)> 2.0*the upper limit of normal (ULN); 8. creatinine clearance rate 265.2umol/L; 9. Alcohol abuse or drug abuse; 10. Involving in other clinical trial; 11. Allergy to digoxin; 12. Cardiac function > II grade or lung function >grade II.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| os;PF; | — |
Countries
China
Contacts
Public ContactOUYANG JIAN
Outcome results
None listed